CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

NorthStar's China CRO deal; Lonza details midterm guidance

PartnershipNeutral
AI Analysis

Summary

NorthStar Medical Technologies partnered with Beijing-based CRO Quarkmed for radioisotope research services. Lonza released midterm guidance details alongside updates on Triastek, Scinai, and HydRegen.

Financial Highlights

Guidance

Lonza midterm guidance mentioned

Importance:3/10
Sentiment:
0.00
partnershipCROradioisotopeChinaguidance
Related Companies

Read the original article

Published by Endpoints News on October 15, 2026 3:21 PM

Read Original